Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,289 | 34,263 | 25,869 | 40,031 | 9,565 |
| TOTAL | $24,250 | $35,899 | $27,905 | $41,368 | $10,453 |
| Non-Current Assets | |||||
| PPE Net | 757 | 910 | 979 | 1,023 | 1,090 |
| Other Non-Current Assets | 467 | 484 | 501 | 517 | 532 |
| TOTAL | $1,224 | $1,394 | $1,479 | $1,540 | $1,622 |
| Total Assets | $25,474 | $37,293 | $29,385 | $42,908 | $12,076 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,585 | 8,304 | 6,463 | 7,394 | 9,179 |
| Other current liabilities | 1,718 | 11,929 | 8,628 | 21,083 | 16,121 |
| TOTAL | $9,388 | $20,314 | $15,168 | $28,551 | $25,359 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,792 | 1,814 | 1,836 | 1,856 | 1,876 |
| TOTAL | $1,792 | $1,814 | $1,836 | $1,856 | $1,876 |
| Total Liabilities | $11,179 | $22,128 | $17,004 | $30,407 | $27,235 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,534 | 1,374 | 1,351 | 1,194 | 1,074 |
| Retained earnings | -247,343 | -244,987 | -230,322 | -229,403 | -202,761 |
| Other shareholders' equity | 0 | 4,369 | 7,844 | 17,068 | 0 |
| TOTAL | $14,295 | $15,165 | $12,381 | $12,501 | $-15,159 |
| Total Liabilities And Equity | $25,474 | $37,293 | $29,385 | $42,908 | $12,076 |